Sanofi (France) Sues Eli Lilly and Company Over Insulin Rival To Lantus

(Reuters) - Sanofi SA, whose top-selling Lantus helps diabetics control blood sugar levels, has filed a lawsuit accusing Eli Lilly and Co of infringing seven patents related to insulin and devices used to deliver it.

Through its complaint made public on Tuesday in the U.S. District Court in Wilmington, Delaware, Sanofi is seeking to halt Lilly's proposed commercial marketing in the United States of a rival treatment, known as Abasria, saying the sale would violate its rights.

Help employers find you! Check out all the jobs and post your resume.